Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 21Lymphoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 7Leukemia 6Hodgkin Disease 6Neoplasm Metastasis 5Lymphoma, B-Cell 4Burkitt Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell, Marginal Zone 3Hemangioma 3Recurrence 2Neoplasms 2Neoplasm, Residual 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Dendritic Cell Sarcoma, Interdigitating 2Breast Neoplasms 2Thymoma 1Stomatitis 1Prostate Cancer Metastatic 1Philadelphia Chromosome 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

ibrutinib 5fludarabine 4Rituximab 4Lenalidomide 3Busulfan 3thymoglobulin 2fludarabine phosphate 2blinatumomab 2Vincristine 2Methotrexate 2Melphalan 2Bendamustine Hydrochloride 2Behavior Therapy 2Alemtuzumab 2tozasertib 1sargramostim 1romiplostim 1pirtobrutinib 1pegaspargase 1palbociclib 1ofatumumab 1obinutuzumab 1mocetinostat 1lirilumab 1forodesine 1fenebrutinib 1enzastaurin 1duvelisib 1Stem Cell Transplantation 1RFT5-SMPT-dgA immunotoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Lymphoid × Prednisolone × Clear all
NCT03792256 2025-03-21

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Children's Oncology Group

Phase 1 Completed
12 enrolled 24 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Recurrence, Leukemia, T-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡